✦ LIBER ✦

PCN60 COST-EFFECTIVENESS OF PEGFILGRASTIM VERSUS FILGRASTIM AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MYELOMA

✍ Scribed by L. Perrier; A. Lefranc; P. Quittet; P. Moreau; C. Siani; H. Ghesquières; F. Jardin; B. Favier; N. Ifrah; S. Lissandre; D. Pérol; C. Sebban

Book ID: 119309671
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 60 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.02.915

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegfilgrastim compared with filgrastim a

Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients

✍ Massimo Martino; Giulia Praticò; Giuseppe Messina; Giuseppe Irrera; Elisabetta M 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Pegfilgrastim versus filgrastim to accel

Pegfilgrastim versus filgrastim to accelerate hematopoietic recovery after high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma

✍ R.L. Olin; S.M. Luger; D.L. Porter; S.J. Schuster; D. Tsai; S. Nasta; A. Perl; A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Early versus late administration of pegf

Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation

✍ C. Kahl; H. G. Sayer; A. Hinke; M. Freund; J. Casper 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 303 KB

Pegfilgrastim compared with filgrastim a

Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas

✍ Alberto Ballestrero; Davide Boy; Roberta Gonella; Maurizio Miglino; Marino Clavi 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 137 KB

Comparison of fixed dose pegfilgrastim a

Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis

✍ Felicetto Ferrara; Tiziana Izzo; Clelia Criscuolo; Cira Riccardi; Assunta Viola; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract Different authors have explored the feasibility of autografting patients with multiple myeloma (MM) on an outpatient basis. Peg‐filgrastim (PEG), a long‐acting recombinant G‐CSF, has similar efficacy when compared to conventional G‐CSF for chemotherapy‐induced neutropenia, but little is

A randomised phase II study of the effic

A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)

✍ C. Sebban; A. Lefranc; L. Perrier; P. Moreau; D. Espinouse; A. Schmidt; L. Kammo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 442 KB